Evaluating the efficacy of Hip1R, Vimentin, and H3K27me3 as surrogate markers for 1p/19q co-deletion in oligodendrogliomas
The study demonstrates that the combinations of the three immunohistochemical markers HIP1R, Vimentin, and H3K27me3 can accurately predict 1p/19q co-deletion status in IDH-mutant gliomas. This method offers a reliable, robust, cost-effective alternative to complex techniques like FISH.
Authors
- Sumanta Das (ORCID: https://orcid.org/0000-0003-3592-9533)
- Chitra Sarkar (ORCID: https://orcid.org/0000-0002-4315-9316)
- Saumya Sahu
- Vaishali S. Suri (ORCID: https://orcid.org/0000-0001-6485-8194)
- Hemlata Jangir (ORCID: https://orcid.org/0000-0002-8357-8347)
- Ashish Suri (ORCID: https://orcid.org/0000-0002-0464-0860)
- Mehar C. Sharma
- Charli Roy
- Ashish Wadekar
Institutions
- All India Institute of Medical Sciences (IN)
Publication Details
- Journal
- Neuro-Oncology Advances
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1093/noajnl/vdaf060
- Citations
- 2
- Primary Topic
- Glioma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 3.25